GC
CLB icon

Gratry & Company’s Core Laboratories CLB Stock Holding History

Gratry & Company’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,265
Closed -$528K – 80
2016
Q2 		$528K Buy
+4,265
New +$515K 0.42% 38

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM

Gratry & Company's CLB Position: Q3 2016 in Review

Gratry & Company sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 4,265 shares — an estimated $528K sold.

Gratry & Company first reported a position in CLB in Q2 2016 and held it in 1 quarter. The position peaked at $528K in Q2 2016. 372 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

  • Gratry & Company reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
  • Gratry & Company sold 4,265 Core Laboratories shares in Q3 2016, an estimated $528K.
  • Gratry & Company first reported a position in Core Laboratories in Q2 2016 and held it in 1 quarter.
  • Gratry & Company's Core Laboratories position peaked at $528K in Q2 2016.
  • 372 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Gratry & Company's 13F filing for Q3 2016, filed 4 Nov 2016.